Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shigeru Shibata

Showing results (81-90 of 162) with videos related to

Pageof 17
Sort By:
Oxidative Medicine and Cellular Longevity|March 25, 2017
Podocyte Injury and Albuminuria in Experimental Hyperuricemic Model RatsShinichiro Asakawa, Shigeru Shibata, Chikayuki Morimoto, et al.
Biochemical and Biophysical Research Communications|February 21, 2019
Group I metabotropic glutamate receptor activation induces TRPC6-dependent calcium influx and RhoA activation in cultured human kidney podocytesQin Wang, Derun Wang, Shigeru Shibata, et al.
Biomedical Research (Tokyo, Japan)|May 16, 2008
Decreased expression of claudin-1 is correlated with recurrence status in esophageal squamous cell carcinomaKeiichi Miyamoto, Tomomi Kusumi, Fuyuki Sato, et al.
BMC Nephrology|November 26, 2024
Erythrocyte indices and response to hypoxia-inducible factor prolyl hydroxylase inhibitors in chronic kidney disease patients with renal anemia: a retrospective studyKohei Odajima, Shigeyuki Arai, Ryo Kido, et al.
Hypertension (Dallas, Tex. : 1979)|September 25, 2024
ENaCγ in Urinary Extracellular Vesicles as an Indicator of MR Signaling in Primary AldosteronismYuto Hayama, Emiko Kuribayashi-Okuma, Norihiko Fujii, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 18, 2005
[A Case of advanced gastric cancer successfully treated with TS-1/low-dose CDDP as neoadjuvant chemotherapy]Kyogo Yamada, Yuzuru Sugiyama, Kageyoshi Seino, et al.
Hypertension (Dallas, Tex. : 1979)|June 1, 2021
Activation of Rac1-Mineralocorticoid Receptor Pathway Contributes to Renal Injury in Salt-Loaded <i>db/db</i> MiceDaigoro Hirohama, Mitsuhiro Nishimoto, Nobuhiro Ayuzawa, et al.
Nature Medicine|November 26, 2008
Modification of mineralocorticoid receptor function by Rac1 GTPase: implication in proteinuric kidney diseaseShigeru Shibata, Miki Nagase, Shigetaka Yoshida, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|May 17, 2005
Two cases of renovascular hypertension and ischemic renal dysfunction: reliable choice of examinations and treatmentsKatsuyuki Ando, Katsutoshi Takahashi, Shigeru Shibata, et al.
BMC Nephrology|November 29, 2017
Unique proximal tubular cell injury and the development of acute kidney injury in adult patients with minimal change nephrotic syndromeYoshihide Fujigaki, Yoshifuru Tamura, Michito Nagura, et al.
Pageof 17

Showing results (81-90 of 162) with videos related to

Sort By:
Pageof 17
Oxidative Medicine and Cellular Longevity|March 25, 2017
Podocyte Injury and Albuminuria in Experimental Hyperuricemic Model RatsShinichiro Asakawa, Shigeru Shibata, Chikayuki Morimoto, et al.
Biochemical and Biophysical Research Communications|February 21, 2019
Group I metabotropic glutamate receptor activation induces TRPC6-dependent calcium influx and RhoA activation in cultured human kidney podocytesQin Wang, Derun Wang, Shigeru Shibata, et al.
Biomedical Research (Tokyo, Japan)|May 16, 2008
Decreased expression of claudin-1 is correlated with recurrence status in esophageal squamous cell carcinomaKeiichi Miyamoto, Tomomi Kusumi, Fuyuki Sato, et al.
BMC Nephrology|November 26, 2024
Erythrocyte indices and response to hypoxia-inducible factor prolyl hydroxylase inhibitors in chronic kidney disease patients with renal anemia: a retrospective studyKohei Odajima, Shigeyuki Arai, Ryo Kido, et al.
Hypertension (Dallas, Tex. : 1979)|September 25, 2024
ENaCγ in Urinary Extracellular Vesicles as an Indicator of MR Signaling in Primary AldosteronismYuto Hayama, Emiko Kuribayashi-Okuma, Norihiko Fujii, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 18, 2005
[A Case of advanced gastric cancer successfully treated with TS-1/low-dose CDDP as neoadjuvant chemotherapy]Kyogo Yamada, Yuzuru Sugiyama, Kageyoshi Seino, et al.
Hypertension (Dallas, Tex. : 1979)|June 1, 2021
Activation of Rac1-Mineralocorticoid Receptor Pathway Contributes to Renal Injury in Salt-Loaded <i>db/db</i> MiceDaigoro Hirohama, Mitsuhiro Nishimoto, Nobuhiro Ayuzawa, et al.
Nature Medicine|November 26, 2008
Modification of mineralocorticoid receptor function by Rac1 GTPase: implication in proteinuric kidney diseaseShigeru Shibata, Miki Nagase, Shigetaka Yoshida, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|May 17, 2005
Two cases of renovascular hypertension and ischemic renal dysfunction: reliable choice of examinations and treatmentsKatsuyuki Ando, Katsutoshi Takahashi, Shigeru Shibata, et al.
BMC Nephrology|November 29, 2017
Unique proximal tubular cell injury and the development of acute kidney injury in adult patients with minimal change nephrotic syndromeYoshihide Fujigaki, Yoshifuru Tamura, Michito Nagura, et al.
Pageof 17